Amneal agrees to acquire Kashiv BioSciences for $750 million

April 22, 2026 6:00 AM

Amneal Pharmaceuticals Inc. (NASDAQ: AMRX) announced it will acquire 100% of Kashiv BioSciences, LLC in a transaction valued at $750 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found